As of 2025-12-29, the EV/EBITDA ratio of Gritstone Oncology Inc (GRTS) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GRTS's latest enterprise value is -8.76 mil USD. GRTS's TTM EBITDA according to its financial statements is -124.44 mil USD. Dividing these 2 quantities gives us the above GRTS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 15.3x | 14.0x |
| Forward P/E multiples | 22.2x - 43.4x | 32.8x |
| Fair Price | (54.37) - (37.41) | (57.32) |
| Upside | -168947.8% - -116269.9% | -178109.2% |
| Date | EV/EBITDA |